FIELD: chemistry.
SUBSTANCE: invention relates to a dosage form of a pyrimidinedione derivative of 3N-amino-6-methyl-1H-pyrimidine-2,4-dione of formula given below:
Proposed inhalation dosage form contains 3N-amino-6-methyl-1H-pyrimidine-2,4-dione, sodium hydrocarbonate (NaHCO3), benzalkonium chloride/bromide, water at a certain ratio.
EFFECT: inhalation dosage form possesses high pharmacological activity and increases efficiency of adjuvant therapy of lung adenocarcinoma.
1 cl, 2 dwg, 1 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| MACROHETEROCYCLIC NUCLEOSIDE DERIVATIVES AND ANALOGUES THEREOF, PRODUCTION AND USE | 2017 |
|
RU2731385C1 |
| NEW DISPIRO-INDOLINONES, MDM2/p53 INTERACTION INHIBITORS, METHOD FOR PRODUCTION AND APPLICATION | 2015 |
|
RU2629750C2 |
| DISPIROINDOLINONES BASED ON RHODANINES AS P53-MDM2 INHIBITORS OF PROTEIN-PROTEIN INTERACTION | 2019 |
|
RU2730286C1 |
| PHARMACEUTICAL COMPOSITION BASED ON 6-[(4-METHYL-1-1-PIPERAZINYL)METHYL]-INDOLO[1',7':1,2,3]PYRROLO[3',4':6,7]AZEPINO[4,5-b]INDOLE-1,3(2H,10 H)-DIONE AS ANTI-TUMOUR MEDICATION | 2013 |
|
RU2523387C1 |
| USE OF 3-O-SULFAMOYLOXY-7Β-METHYL-D-HOMO-6-OXAESTRA-1,3,5(10),8(9)-TETRAEN-17A-ONE FOR THE TREATMENT OF BREAST CANCER, INCLUDING A TRIPLE NEGATIVE FORM | 2018 |
|
RU2678845C1 |
| PROCESS FOR PRODUCING DERIVATIVES OF XANTHINE OR THEIR SALTS | 0 |
|
SU952105A3 |
| CYCLIC DEOXYRIBONUCLEOTIDE COMPOUNDS | 2020 |
|
RU2836016C2 |
| PHARMACEUTICAL COMPOSITION, METHODS FOR ITS PREPARING AND APPLYING | 2003 |
|
RU2248978C1 |
| NEW COMBINATION OF 3-[(3-{[4-(4-MORPHOLINYLMETHYL)-1N-PYRROL-2-YL]METHYLENE}-2-OXO-2,3-DIHYDRO-1N-INDOL-5-YL)METHYL]-1,3-THIAZOLIDINE-2,4-DIONE AND TYROSINE KINASE INHIBITOR EGFR | 2016 |
|
RU2695362C2 |
| NUCLEOTIDES INCLUDING N-[(S)-1-CYCLOBUTOXYCARBONYL]PHOSPHORAMIDATE FRAGMENT, THEIR ANALOGS AND THEIR APPLICATION | 2017 |
|
RU2659388C1 |
